Demand for Pharma Blisters Packaging Will Remain Robust In Medical Compliance by using Polyethylene Terephthalate

The pharma blister packaging market is estimated to reach US$ 10.5 Bn in 2022 and is projected to reach US$ 19 Bn by 2032, at a 6% CAGR from 2022-2032. Fact.MR – a market research and competitive intelligence provider, envision a moderate growth in demand of pharma blisters packaging market.

The packaging industry is estimated to be valued at around US$ 300 Bn, wherein pharma packaging industry is estimated to account for around 4% of the market share in 2022. Moreover, global pharma blister packaging market is evaluated to reach US$ 15 Bn, in which 70% of the market share will be captured by the pharma blister packing market. However, under the umbrella of the global pharma packaging industry, pharma blisters packaging market accounts for more than 85% of market share and valued around US$ 9.8 Bn in 2020.

The last decade was crucial for pharma industry, as the global market landscape has been revised drastically. Until mid-1990’s U.S, Europe and Japan was catering the 90% of worldwide APIs (Active Pharmaceutical Ingredient) demand. However, evolving market clusters, trade affairs and shifting manufacturing base has turned the table towards the Asia Pacific region in last ten years. As per the recent study, China manufactures more than 40% of all APIs across the globe, nonetheless India and China are the keen source and accounting for more than 75% of APIs imports to US.

5 Highlights from Fact.MR’s Forecast

  • In 2017, around 738 thousand tons of carded blister packs have been sold in the global pharmaceuticals industry. However, the report estimates that the demand for carded packs will dwindle in the global pharma blisters packaging market towards the end of the forecast period. Meanwhile, clamshell blister packs will represent the fastest-selling product in the global pharma blisters packaging market, reflecting a volume CAGR of 6% over the forecast period.
  • Through 2026, thermoforming technology will be predominantly used in the production of blister packages for pharmaceutical products. The report estimates that by the end of 2026, nearly 1,290 thousand tons of thermoformed blisters will be sold across the global pharma blisters packaging market. Cold forming technology will also gain traction in the global pharma blisters packaging market, and will register a robust volume CAGR of 6.5% during the forecast period.
  • By the end of 2026, high-density polyethylene (HDPE) and aluminum will represent the two widely-used materials for pharma blisters packaging. Nevertheless, polyethylene terephthalate will register highest use as a key materials for manufacturing blister packs.
  • In 2018 and beyond, tablets will be the largest application in the global pharma blisters packaging market. By the end of 2026, more than 1,000 thousand tons of pharma blisters packaging products will be used in tablets applications across the globe. The report also estimates that throughout the forecast period, over 50% of the global pharma blisters packaging market volumes will be used in tablets applications.
  • In terms of regions, North America is pegged to represent the largest market for pharma blisters packaging, accounting for the fastest expansion at a volume CAGR of 6.5% over the forecast period. The report also estimates that Europe’s pharma blisters packaging market will expand robustly, accounting for approximately one-fourth share of global market volumes over the forecast period.

How Eco-Friendly Blister Packaging is Reducing Cost?

In order to minimize carbon footprints and contribute towards green environment, manufacturers are shifting towards sustainability and adopting eco-friendly raw materials for blister packages. For instance, Bilcare Research Inc., a manufacturer of blister packaging launched ECOmply that blends PVC film with special additive to make it biodegradable. Similarly, manufacturers are investing in the research and development activities to develop eco-friendly and cost-effective pharma blister packaging that can withstand thermal, mechanical and biological stress during blister forming process.

Companies have also started procuring eco-friendly blister packaging machines, suitable for packaging products from low-high volume production capabilities. However, using sustainable packaging can be challenging in the pharmaceutical industry where there are stringent safety regulations. Market front runners are undergoing self-assessment in order to develop robust triple bottom line approach for gaining higher profits, streamlining distribution network as well as developing sustainable product portfolio.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Leave a Reply

Your email address will not be published. Required fields are marked *